最新发布第2页
NeurologyLive® Brain Games: May 12, 2024-爱医学

NeurologyLive® Brain Games: May 12, 2024

Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topi...
eason的头像-爱医学eason11个月前
420
Basal Ganglia Activity Associated With REM Sleep Behavior Disorder in Parkinson Disease-爱医学

Basal Ganglia Activity Associated With REM Sleep Behavior Disorder in Parkinson Disease

Jian-Guo Zhang, MD, PhD(Credit: Capital Medical University)Newly published in the Journal of Neurology, Neurosurgery and Psychiatry, findings showed that basal ganglia activities a...
eason的头像-爱医学eason11个月前
360
CSF Anti-DAGLA Autoantibodies Identified as Potential Biomarker of Rapidly Progressive Cerebellitis-爱医学

CSF Anti-DAGLA Autoantibodies Identified as Potential Biomarker of Rapidly Progressive Cerebellitis

Kurt-Wolfram Sühs, MD(Credit: Hannover Medical School)In a small-scale study published in the Journal of Neurology, Neurosurgery & Psychiatry, investigators identified diacylglyce...
eason的头像-爱医学eason11个月前
380
PrimeC Performs Well in High-Risk ALS, Patient Death Reported in DAYLIGHT Trial, Donanemab AdComm Hearing Date Announced-爱医学

PrimeC Performs Well in High-Risk ALS, Patient Death Reported in DAYLIGHT Trial, Donanemab AdComm Hearing Date Announced

WATCH TIME: 4 minutesWelcome to this special edition of Neurology News Network. I’m Marco Meglio.Newly announced analyses from the phase 2b PARADIGM trial showed that treatment wi...
Cell Therapy Reveals Early Promise in Addressing Motor and Non-Motor Symptoms for Parkinson Disease-爱医学

Cell Therapy Reveals Early Promise in Addressing Motor and Non-Motor Symptoms for Parkinson Disease

Claire Henchcliffe, MD(Credit: Weill Cornell Medicine)According to a recent report from GlobalData, using data from BlueRock Therapeutics’ phase 1 study (NTC04802733) assessing be...
eason的头像-爱医学eason11个月前
650
NeurologyLive® Friday 5 — May 10, 2024-爱医学

NeurologyLive® Friday 5 — May 10, 2024

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and...
eason的头像-爱医学eason11个月前
490
Depression Predisposes Parkinson Disease, Associated With Worse Disease Severity-爱医学

Depression Predisposes Parkinson Disease, Associated With Worse Disease Severity

Using data from more than 430,000 participants with 14.1 years of follow-up, findings from a recently published study showed that depression is common in patients with Parkinson di...
eason的头像-爱医学eason11个月前
410
Early Treatment Response and Safety Profile of AXS-05 in Phase 3 ACCORD Trial: Anton P. Porsteinsson, MD-爱医学

Early Treatment Response and Safety Profile of AXS-05 in Phase 3 ACCORD Trial: Anton P. Porsteinsson, MD

WATCH TIME: 6 minutes'It's important because when patients finally seek treatment for agitation and aggression that’s been going on for quite a while and has gotten to a critical ...
Criteria for Changing Treatment in Narcolepsy: Part 2-爱医学

Criteria for Changing Treatment in Narcolepsy: Part 2

This is a video synopsis/summary of a panel discussion involving Michael Thorpy, MD; Karl Doghramji, MD, FAASM, DFAPA; Clete Kushida, MD, PhD; and Richard K Bogan, MD.The discussio...
eason的头像-爱医学eason11个月前
430
Criteria for Changing Treatment in Narcolepsy: Part 1-爱医学

Criteria for Changing Treatment in Narcolepsy: Part 1

This is a video synopsis/summary of a panel discussion involving Michael Thorpy, MD; Karl Doghramji, MD, FAASM, DFAPA; Clete Kushida, MD, PhD; and Richard K Bogan, MD.Experts discu...
eason的头像-爱医学eason11个月前
430